{
    "clinical_study": {
        "@rank": "83831", 
        "arm_group": {
            "arm_group_label": "Fampyra group"
        }, 
        "brief_summary": {
            "textblock": "The aim of the study is to assess improvement in visual evoked potential, cognition,\n      fatigue, micturation and walking impairment under 3 months of Fampyra treatment"
        }, 
        "brief_title": "Efficiency of 4-aminopyridin (Fampyra) on Gait, Vision, Cognition, Fatigue and Micturation in Patients With Multiple Sclerosis", 
        "condition": [
            "Multiple Sclerosis", 
            "EDSS 4-7"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Multiple Sclerosis", 
                "Sclerosis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        All patients who according to the compound's Norwegian prescription guidelines are deemed\n        eligible for the study, i.e. MS patients with impaired walking as determined by an EDSS\n        4-7. They do not need a past history of optic neuritis, cognitive failure, fatigue or\n        difficulties micturating.\n\n        Exclusion Criteria:\n\n        MS patients with contraindications to the compound according to the prescription\n        guidelines.\n\n        Patients who have been exposed to Fampyra in the past Patients with an MS attack within\n        last 3 months"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "All patients who according to the compound's Norwegian prescription guidelines are deemed\n        eligible for the study, i.e. MS patients with impaired walking as determined by an EDSS\n        4-7. They do not need a past history of optic neuritis, cognitive failure, fatigue or\n        difficulties micturating."
            }
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 31, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01720849", 
            "org_study_id": "FampyraCSS"
        }, 
        "intervention": {
            "arm_group_label": "Fampyra group", 
            "description": "The will be given as per normal patient treatment plan", 
            "intervention_name": "Fampyra", 
            "intervention_type": "Drug"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "November 1, 2012", 
        "location": {
            "contact": {
                "email": "ceciliasimonsen@yahoo.co.uk", 
                "last_name": "Cecilia S Simonsen, MBChB", 
                "phone": "+4798673256"
            }, 
            "facility": {
                "address": {
                    "city": "Drammen", 
                    "country": "Norway", 
                    "zip": "3004"
                }, 
                "name": "Vestre Viken Helseforetak"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Norway"
        }, 
        "number_of_groups": "1", 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": [
                "Norway: Regional Ethics Commitee", 
                "Norway: Data Protection Authority"
            ]
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "change from baseline in visual evoked potential after 2 weeks and 3 months", 
            "safety_issue": "No", 
            "time_frame": "5 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01720849"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Vestre Viken Hospital Trust", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Vestre Viken Hospital Trust", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "October 2012"
    }
}